About INC Research
INC Research is a publicly listed company based in Raleigh (United States) founded in 1998, and was acquired by Avista Capital Partners in August 2010. Global CRO services for Phase I-IV clinical development are offered. INC Research has completed 3 acquisitions, including Adv Biol, Syneos Health and inVentiv Health. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is INC RESEARCH INC. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.
Company details
INC Research is a full-service CRO offering clinical development services right from Phase I to Phase IV for biopharmaceutical and medical device industries. It offers customised phase I to phase IV programs in a wide range of therapeutic areas including oncology, CNS diseases, infectious diseases, endocrinology, immunology and inflammation, and paediatric and womens health. The company offers its services through a therapeutically aligned delivery model and active engagement through its site relationships. INC Research is the first CRO to sponsor SCRS (Society of Clinical Research Sites) Scholarships and claims to be the first CRO to utilise Site Advocacy Groups. INC Researchs CRO services portfolio includes clinical trial management (including patient recruitment and retention), data management and biostatistics, regulatory affairs, medical writing and post-approval services (Safety surveillance, health outcomes research etc.,). The Company was named Best Contract Research Organization in December 2015 by an independent panel for Scrip Intelligence. INC Research claims to be the only CRO to rank consistently among the top three CROs in all seven CenterWatch site relationship surveys conducted since 2007. INC Research has experience in conducting clinical trials in 110 countries spanning six continents.
- Headquarters Raleigh, United States
- Stage Public
- SectorsHealthcare
- Website incresearch.com
- Social LinkedIn X
- Acquired by Avista Capital Partners (Aug 2010)
- Legal Name Inc Research Inc
- Latest Funding Round$4.54M (USD), Grant
Dec 2017
- InvestorsEuropean Union
& 2 more
- Investments & AcquisitionsAdv Biol
& 2 more
- Acquired byAvista Capital Partners
(Aug 2010)
Funding Insights of INC Research
- Total Rounds 1
- Last Round Grant — $4.54M
- First Round $4.54M
(Dec 2017)
- Investors Count 1
All 1 funding rounds of INC Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2017 | $4.54M | Grant | – | – |
3 investors in total: 3 institutional.
Investors in INC Research
INC Research has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Union, Ontario Teachers' Pension Plan and Avista Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Private equity investments are focused on the United States market. | avistacap.com | New York, United States | ||
Pension funds focused on multiple sectors | 1990 | otpp.com | Toronto, Canada |
Investor details for INC Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of INC Research
554 people are tracked at INC Research (256 in leadership, 2 in board & advisors, 296 in team).
| Name | Role | Group |
|---|---|---|
Tammy D'Lugin-Monroe | Senior Vice President, Head, Site Activation | Leadership |
Shannon Graff O'Dear | Sr. Director, Strategy And Delivery | Leadership |
Leigh Ann Bruhn | Executive Vice President - Head Of Value, Access & Policy | Leadership |
Chris O'Day | Vp, Commercial Solutions Development | Leadership |
Warren Aronson | Vice President Strategic Operations | Leadership |
Peter Wilkinson | EVP & CFO - Clinical Solutions | Leadership |
Michael Bonello | Executive Vice President And Chief Financial Officer | Leadership |
Donna Kralowetz | Evp, Chief Accounting Officer | Leadership |
Anna Ching | Associate Director, APAC Clin Ops Support | Leadership |
Mac Rich | Executive Director, Operations Management | Leadership |
Thomas Wollman | Global Head, Operational Excellence | Leadership |
Beth Eisenberg | Director, BU Operations| Clinical Surveillance & Training| Medical And Scientific Management | Leadership |
Alok Patel | Director, Regulatory Consulting | Leadership |
Sreedhar Adusumilli | Director, IT | Leadership |
John Tanner | Executive Director Information Technology | Leadership |
Gitanjali Scindia | Director, Proposals/ RFI | Leadership |
Scott Steward | Senior Director Business Development | Leadership |
Gloria Liu | Director, Site & Patient Access | Leadership |
Dheerja Sikka | Executive Director, Financial Planning And Analysis | Leadership |
Max Ghez | Global Head, Clinical Business Development | Leadership |
534 more people are available in the full profile.
Complete people profiles for INC Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by INC Research
INC Research has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Adv Biol, Syneos Health and inVentiv Health.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Contract research and commercialization services are provided to biopharmaceutical industries. | inventivhealth.com | Burlington, United States | 1999 | May 2017 | $4.6B | |
Global CRO services for Phases I-IV clinical development are provided. | kendle.com | Northbrook, United States | 1981 | Jul 2011 | $232M | |
Biologic therapies are developed and advanced for medical use. | advbiol.com | New Hope, United States | 1995 | Apr 2007 | •••• |
Complete acquisition details for INC Research
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of INC Research
7 dated milestones of INC Research across 19 years, from founding to its latest funding, stage changes and deals.
- Founded INC Research is founded.
- Acquisition Acquires Adv Biol.
- Exit Acquired by Avista Capital Partners.
- Acquisition Acquires Syneos Health.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires inVentiv Health.
- Funding First funding round of $4.5M.
Competitors of INC Research
INC Research has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. |
Detailed competitors of INC Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of INC Research
Websites that share an audience with INC Research (incresearch.com).
Websites whose visitors overlap most with INC Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
studies4u.com | studies4u.com | 100% | – | ||
| iris-pharma.com | 89% | 2.2K | #10,426,473 | View details | |
| covance.com | 87% | 20.2K | #688,229 | View details | |
focus-cdd.de | focus-cdd.de | 86% | – | ||
pharmaasia.com | pharmaasia.com | 86% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for INC Research
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as INC Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about INC Research
INC Research was founded in 1998 and raised its 1st funding round 19 years after it was founded.
INC Research is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
INC Research is a full-service CRO offering clinical development services right from Phase I to Phase IV for biopharmaceutical and medical device industries. It offers customised phase I to phase IV programs in a wide range of therapeutic areas including oncology, CNS diseases, infectious diseases, endocrinology, immunology and inflammation, and paediatric and womens health. The company offers its services through a therapeutically aligned delivery model and active engagement through its site relationships. INC Research is the first CRO to sponsor SCRS (Society of Clinical Research Sites) Scholarships and claims to be the first CRO to utilise Site Advocacy Groups. INC Researchs CRO services portfolio includes clinical trial management (including patient recruitment and retention), data management and biostatistics, regulatory affairs, medical writing and post-approval services (Safety surveillance, health outcomes research etc.,). The Company was named Best Contract Research Organization in December 2015 by an independent panel for Scrip Intelligence. INC Research claims to be the only CRO to rank consistently among the top three CROs in all seven CenterWatch site relationship surveys conducted since 2007. INC Research has experience in conducting clinical trials in 110 countries spanning six continents.
INC Research's top competitors include Syneos Health, Medelis WCCT Global and Celgene.
INC Research has made 3 acquisitions, including Adv Biol, Syneos Health, and inVentiv Health.
INC Research has 3 investors. Key investors include European Union, Ontario Teachers' Pension Plan, and Avista Capital Partners.
INC Research operates through Inc Research Inc.
Yes. INC Research was acquired by Avista Capital Partners in August 2010.